Stem Cell Therapy For Stroke Stanford

The patients all of whom had suffered their first and only stroke between six months and three years before receiving the.

Stem cell therapy for stroke stanford.

Injecting modified human adult stem cells directly into the brains of chronic stroke patients proved not only safe but effective in restoring motor function according to the findings of a small clinical trial led by stanford university school of medicine investigators. When steinberg started looking into stem cell therapy for stroke patients in the early 2000s the idea was still unorthodox. Stem cell therapy offers enormous promise for the majority of the 795 000 americans yearly who suffer a stroke yet currently have no pharmacological therapy to promote recovery. The program brings together world renowned scientists from a wide variety of.

The primary purpose of the clinical study is to determine the safety of a modified stem cell sb623 when administered to chronic stable ischemic stroke patients. Stanford is currently not. Stem cells start off unspecialized but as they divide they can grow into particular cell types. This has led to major efforts to advance stem cell therapy for stroke to the clinic including our.

Preclinical data from our lab and others have demonstrated that stem cell transplantation can enhance stroke recovery. And with only this one prior stroke and and with no further improvement from physical therapy. Based at stanford university the program is uniquely positioned to bridge the barriers between neuroscience engineering and clinical research to develop new therapies for stroke survivors. A study of modified stem cells in stable ischemic stroke.